Rare diseases
Investigational molecules
Locations
Study on Ustekinumab and Guselkumab for Children with Active Juvenile Psoriatic Arthritis
DenmarkStudy on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis
DenmarkStudy of secukinumab and prednisone combination therapy for patients with giant cell arteritis (GCA): Evaluation of treatment effectiveness and safety
DenmarkStudy on Acalabrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients Without del(17p) or TP53 Mutation
DenmarkStudy of Encorafenib, Cetuximab, and Pembrolizumab for Patients with Untreated BRAF V600E-Mutant Metastatic Colorectal Cancer
DenmarkStudy of Tucatinib and Ado-Trastuzumab Emtansine for Patients with Advanced HER2+ Breast Cancer
DenmarkStudy on Enzalutamide and Leuprorelin Acetate for Men with High-Risk Nonmetastatic Prostate Cancer After Treatment
DenmarkStudy on Repotrectinib for Patients with Advanced Solid Tumors with ALK, ROS1, or NTRK1-3 Gene Changes
DenmarkStudy on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis
DenmarkStudy on the Effects of Casimersen and Golodirsen for Patients with Duchenne Muscular Dystrophy Amenable to Exon 45 or 53 Skipping
DenmarkStudy on the Safety and Tolerability of DNTH103 for Adults with Generalized Myasthenia Gravis
DenmarkStudy on the Effectiveness and Safety of Mitapivat for Patients with Non-Transfusion-Dependent Alpha or Beta Thalassemia
DenmarkTell us about your condition – we search every trial in Europe and connect you with the right site.
